It’s been a decade since the first checkpoint inhibitors were approved, but the problem of low response rates remains in many forms of cancer. Highlight Therapeutics SL, of Valencia, Spain, hopes to ...
SAN JOSE, Calif.--(BUSINESS WIRE)--Calix, Inc. (NYSE: CALX) today announced that CheckPoint Solutions was named the winner of the 2021 Calix Partner Innovation award at Calix ConneXions 2021 in Las ...
KNOXVILLE, TN, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that updated response, safety, and immune correlative data from the Company’s ongoing Phase 1b clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback